-
-
This small proof-of-concept study suggests that yoga may be helpful in patients with highly symptomatic, long-standing paroxysmal atrial fibrillation.
-
The first in a new class of drugs has been approved by the FDA for the treatment of diabetes mellitus. This new class of drugs decreases the renal threshold for glucose excretion by inhibiting the sodium-glucose co-transporter 2 (SGLT2), thus increasing renal clearance of glucose. Canagliflozin is licensed from Mitsubishi Tanabe Pharma Corporation and marketed by Janssen Pharmaceuticals as Invokana.
-
Omalizumab for Asthma in Real Life; Tenofovir: New Hope for Hepatitis B Patients; H. pylori: Frequency of Recurrence After Successful Eradication
-
Statin use among cancer patients with diverse malignancies is associated with reduced cancer-related mortality. The mechanism is plausible since statins inhibit cholesterol synthesis, which reduces the pool of compounds necessary in cellular proliferation and maintenance of critical cellular functions, such as membrane integrity, signaling, protein synthesis, and cell cycle progression. Prospective clinical trials are warranted.
-
This retrospective study of hospitalized patients receiving ceftriaxone found that additional treatment with doxycycline compared to other antibiotics was associated with a lower risk of Clostridium difficile infection.
-
MRI scan was unable to discriminate between patients with favorable outcome and those with an unfavorable outcome when conducted at 1-year follow-up in patients who were treated for sciatica and disk herniation.
-
-
Women over age 40 might underestimate their need for effective birth control; however, despite declining fertility, such women can be at risk for unintended pregnancy.
-
Results of a just-published study indicate a possible method to predict when a woman will have her final menstrual period.1 Such findings might be helpful in aiding women and providers in combatting potential bone loss and cardiovascular risk associated with onset of menopause.